Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Condition

Bullous Pemphigoid

Diseases of the Skin and Subcutaneous Tissue

Bullous pemphigoid is an autoimmune pruritic skin disease that typically occurs in people aged over sixty, that may involve the formation of blisters in the space between the epidermal and dermal skin layers. It is classified as a type II hypersensitivity reaction, which involves the formation of anti-hemidesmosome antibodies, causing a loss of keratinocytes to basement membrane adhesion.

Facts
Classification
Body System
Integumentary System 1
ICD-10 Chapter
XII: Diseases of the Skin and Subcutaneous Tissue 1
Communicable or Non-communicable
Non-Communicable 2
Transmission Route
Non-Transmissible 2
Causative Agent
Causative Agent (category)
Autoimmune 2
Connections

Treated By

Immunosuppressive therapy is a standard treatment for bullous pemphigoid.

Sources
1. Wikipedia: ICD-10
WikipediaList of chapters, Chapter XII
Quote, List of chapters, Chapter XII
Diseases of the skin and subcutaneous tissue
View the Source
2. Wikipedia: Bullous pemphigoid
Wikipedia
  • lead paragraph
    Bullous pemphigoid (a type of pemphigoid) is an autoimmune pruritic skin disease that typically occurs in people aged over 60, that may involve the formation of blisters (bullae) in the space between the epidermal and dermal skin layers.
  • Lead section, disease-category statement
    Bullous pemphigoid (a type of pemphigoid) is an autoimmune pruritic skin disease that typically occurs in people aged over 60, that may involve the formation of blisters (bullae) in the space between the epidermal and dermal skin layers.
  • Lead section, transmission-route statement
    Bullous pemphigoid (a type of pemphigoid) is an autoimmune pruritic skin disease that typically occurs in people aged over 60, that may involve the formation of blisters (bullae) in the space between the epidermal and dermal skin layers.
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.